55 Episodes

  1. Learning from pediatric CAR-T development: insights from manufacturing unique patient doses

    Published: 9/26/2022
  2. Insights into the editing of the human genome: where can novel non-viral polymeric delivery agents take us

    Published: 9/12/2022
  3. Making the switch from autologous to allogeneic cell therapy

    Published: 9/9/2022
  4. Accelerating cures: funding stem cell innovation & ideas in an evolving cell therapy space

    Published: 9/5/2022
  5. Insights into the editing of the human genome: where can novel non-viral polymeric delivery agents take us

    Published: 8/16/2022
  6. Achieving better AAV vector productivity and product quality

    Published: 8/5/2022
  7. Partnering in life sciences: what is the ‘secret sauce’ for success? PART 2

    Published: 7/25/2022
  8. Partnering in life sciences: what is the secret sauce for success? PART 1: The Big Pharma perspective

    Published: 7/18/2022
  9. Where will tomorrow’s workforce come from? PART 4: Who are tomorrow’s cell and gene therapy workers?

    Published: 6/20/2022
  10. Where will tomorrow’s workforce come from? PART 3: Innovation in staff sourcing, training and retention - what works and what doesn’t?

    Published: 6/20/2022
  11. Where will tomorrow’s workforce come from? PART 2: How is the educational system responding, and how can the cell and gene therapy community at large help?

    Published: 6/7/2022
  12. Where will tomorrow’s workforce come from? PART1: Framing the issue

    Published: 6/7/2022
  13. The quest for the Holy Grail in AAV chromatography: empty–full separation

    Published: 5/25/2022
  14. Residual DNA testing in viral vector manufacture: exploring the challenges and solutions

    Published: 5/19/2022
  15. Precisely for CGT: automating aseptic filling for lowest volumes

    Published: 5/10/2022

3 / 3

The BioInsights Podcast: discussing the challenges of translating novel biologics from bench to clinic to market.

Visit the podcast's native language site